Transcatheter aortic valve implantation (TAVI) is considered the safest in nonagenarians, as per Dr Ashok Seth. The observational study at observed that nonagenarians who underwent TAVI had worse short-term outcomes however comparable one-year outcomes as patient younger than 90 years.“The number of nonagenarians (age ninety or above) is growing and in the India is ready to quadruple through 2050 to reach 8. 7 million, he has contributed extensively to the field of Cardiology; specifically, in the matter of Interventional Cardiology, “As such, cardiologists are being confronted with an increasing number of nonagenarian patients with severe aortic stenosis.”
“TAVI has been set up as a popular treatment for most elderly patients with aortic stenosis” persevered Dr. Ashok Seth best cardiologist Fortis Hospital Delhi. “However, there can be a debate about the clinical program of TAVI in some very immoderate hazard subgroups of patients, which encompass nonagenarians, as they've generally represented a small fraction of patients enrolled in scientific trials.”
“We are delighted with the performance and safety outcomes of Transcatheter aortic valve implantation,” said Dr. Ashok Seth best cardiologist Fortis Hospital Delhi. He recently operated on a 92 years old patient at Fortis Heart Institute, New Delhi adopting the TAVI procedure. It is the modern progressive technology in treating heart valve defects and is higher in terms of safety and efficacy.
There is little data on the safety and efficacy of TAVI in patients older than 90 years of age and longer-term (over one year) follow-up is lacking. Dr. Ashok Seth said: “In this actual world observational observe, nonagenarian patients who underwent TAVI had worse quick-term outcomes however similar one-year clinical results as sufferers younger than ninety years. The findings advise that TAVI is safe and effective in nonagenarian sufferers with aortic stenosis and isn't a futile treatment.”
On the basis of these results, best cardiologist Fortis Hospital Delhi comments that “in general” TAVI should be seen as the preferred approach to surgery in patients with a history of CABG. But, he comments that the outcomes with surgical aortic valve replacement “were in fact good”.
So if a patient needs concomitant revascularization that cannot be achieved percutaneously and if the patient is otherwise a good surgical candidate, surgical aortic valve replacement plus CABG with multivessel revascularization might also be considered,” he says.
“About 5 lakh patients, stay untreated due to treatment gap. TAVI accreditation is an accomplishment to lessen these gaps and provide fine services with efficient technology. This procedure is a minimally invasive procedure and is a savior to the patients with severe symptoms of aortic stenosis”, added Dr. Ashok Seth.
Dr. Ashok Seth TAVI Surgeon India
Fortis Heart Institute, Okhla Road, New Delhi
Okhla road, Sukhdev Vihar Metro Station, New Delhi, Delhi 110025
Send Reports for Opinion on WhatsApp : +91-9370586696
Book Immediate Appointment : dr.ashokseth@indiacardiacsurgerysite.com